Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/14/2000 | WO2000075329A1 Targeted angiogenesis |
12/14/2000 | WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
12/14/2000 | WO2000075281A2 Supercritical fluid-assisted nebulization and bubble drying |
12/14/2000 | WO2000075255A2 Pressure sensitive adhesive and biomedical electrodes using same |
12/14/2000 | WO2000075173A2 Peptide fragments of colostrinin |
12/14/2000 | WO2000075115A1 Pernasal preparations |
12/14/2000 | WO2000075079A1 Method for dispersing insoluble mineral sediments and additives for carrying out this method |
12/14/2000 | WO2000074933A1 Composite laminate and method for its production |
12/14/2000 | WO2000074772A1 Iontophoretic drug delivery device and reservoir and method of making same |
12/14/2000 | WO2000074745A1 Drug releasing elastic band and method |
12/14/2000 | WO2000074742A1 Devices and compounds for treating arterial restenosis |
12/14/2000 | WO2000074736A1 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
12/14/2000 | WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
12/14/2000 | WO2000074721A1 Vitamin directed dual targeting therapy |
12/14/2000 | WO2000074720A1 System for release in lower digestive tract |
12/14/2000 | WO2000074714A2 Indicators for monitoring the technique of transcutaneous immunization |
12/14/2000 | WO2000074709A2 Modified biodegradable polyester microspheres for stabilizing and improving the release profile of drugs encapsulated within the microspheres |
12/14/2000 | WO2000074685A1 Oral preparations of etidronate disodium |
12/14/2000 | WO2000074684A1 Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use |
12/14/2000 | WO2000074677A2 Improved pharmaceutical formulations |
12/14/2000 | WO2000074668A1 Non-solid composition for local application |
12/14/2000 | WO2000074661A2 Solubility enhancement of drugs in transdermal drug delivery systems and methods of use |
12/14/2000 | WO2000074660A2 Substrate sections with improved storage stability during their storage in bags, and a method for producing the same |
12/14/2000 | WO2000074659A1 Morphine sulphate microgranules, method for preparing same and compositions containing same |
12/14/2000 | WO2000074658A1 Use of drug-loaded nanoparticles for the treatment of cancers |
12/14/2000 | WO2000074657A1 Methods for coating particles and particles produced thereby |
12/14/2000 | WO2000074656A1 Microencapsulated and controlled-release herbal formulations |
12/14/2000 | WO2000074655A2 Delayed total release two pulse gastrointestinal drug delivery system |
12/14/2000 | WO2000074654A1 Novel preparation and administration form comprising an acid-labile active compound |
12/14/2000 | WO2000074653A1 Oil-core compositions for the sustained release of hydrophobic drugs |
12/14/2000 | WO2000074652A1 Pharmaceutical composition for nasally administering water-soluble active substances |
12/14/2000 | WO2000074651A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water |
12/14/2000 | WO2000074650A2 Implantable gel compositions and method of manufacture |
12/14/2000 | WO2000074649A2 Ophthalmic histamine compositions and uses thereof |
12/14/2000 | WO2000074648A2 Prevention of regression in refractive keratoplasty |
12/14/2000 | WO2000074647A1 Method for enhancing stable cellular creatine concentration |
12/14/2000 | WO2000074646A2 Novel liposomal vector complexes and their use in gene therapy |
12/14/2000 | WO2000074645A1 Aqueous carrier systems for water-insoluble aromatic polymers |
12/14/2000 | WO2000074632A2 Compositions and methods for alleviating discomforting menstrual symptoms |
12/14/2000 | WO2000074618A1 Method and device for producing a product made of strip tape, especially a medical product and/or a product containing active substances as well as fillable receptacles or pouches whose edges can be sealed |
12/14/2000 | WO2000074616A1 Multipurpose first-aid bandage |
12/14/2000 | WO2000074500A1 Compositions containing creatine in suspension |
12/14/2000 | WO2000074489A1 Stable biocidal compositions |
12/14/2000 | WO2000049135A3 Substrate for cell growth |
12/14/2000 | WO2000047758A3 Methods of making compounds |
12/14/2000 | WO2000047716A3 Fibres for culturing eukaryotic cells |
12/14/2000 | WO2000047190A3 Method for producing film-type dosage forms |
12/14/2000 | WO2000047062A3 Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same |
12/14/2000 | WO2000045841A3 Human papilloma virus vaccine formulations |
12/14/2000 | WO2000045770A3 Compressed lecithin preparations |
12/14/2000 | WO2000044681A3 Method for preparing porous shells or gels from glass particles |
12/14/2000 | WO2000044393A3 Buccal delivery system for proteinaceous medicaments |
12/14/2000 | WO2000044348A3 Materials and methods for making improved micelle compositions |
12/14/2000 | WO2000040203A3 Polymeric delivery agents and delivery agent compounds |
12/14/2000 | DE19925710A1 Controlled release dosage form for acid-labile active agents, especially proton pump inhibitors, comprising individual units, especially microspheres, of drug in matrix containing fatty alcohol and solid paraffin |
12/14/2000 | CA2390090A1 Peptides |
12/14/2000 | CA2376311A1 Aqueous carrier systems for water-insoluble aromatic polymers |
12/14/2000 | CA2376261A1 System for release in lower gastrointestinal tract |
12/14/2000 | CA2376258A1 Oral preparations of etidronate disodium |
12/14/2000 | CA2376175A1 Vitamin directed dual targeting therapy |
12/14/2000 | CA2376113A1 Methods for coating particles and particles produced thereby |
12/14/2000 | CA2376108A1 Ophthalmic histamine compositions and uses thereof |
12/14/2000 | CA2375914A1 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
12/14/2000 | CA2375854A1 Novel liposomal vector complexes and their use in gene therapy |
12/14/2000 | CA2375702A1 Nasal preparations |
12/14/2000 | CA2375617A1 Targeted angiogenesis |
12/14/2000 | CA2375371A1 Oil-core compositions for the sustained release of hydrophobic drugs |
12/14/2000 | CA2337853A1 Drug releasing elastomeric ligating band |
12/14/2000 | CA2293162A1 Acidic buffered nasal spray |
12/13/2000 | EP1059092A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
12/13/2000 | EP1059084A2 Rapidly absorbed liquid compositions containing an amine and a NSAID |
12/13/2000 | EP1059083A2 A solid pharmaceutical preparation for dialysis and a process for producing the same |
12/13/2000 | EP1058561A1 Solubilizing delivery systems and method of manufacture |
12/13/2000 | EP1058560A1 Topical ophthalmic preparations containing immunosuppressive agents |
12/13/2000 | EP1058557A1 Enhancement of immunity by intranasal inoculation of il-12 |
12/13/2000 | EP1058556A1 Spray drying of pharmaceutical formulations containing amino acid-based materials |
12/13/2000 | EP1058554A2 Nontoxic vernix compositions and method of producing |
12/13/2000 | EP1058547A1 Pharmaceutical compositions containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
12/13/2000 | EP1058543A1 Hydroxypropylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings |
12/13/2000 | EP1058542A1 Method for producing encased spherical granular grains |
12/13/2000 | EP1058541A1 Sustained-release preparation for aii antagonist, production and use thereof |
12/13/2000 | EP1058540A1 Oral pellet with immediate release comprising glycerides subjected to polyglycolysis, method for making same |
12/13/2000 | EP1058539A1 Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same |
12/13/2000 | EP1058538A1 Fast disintegrating tablets |
12/13/2000 | EP0927196A4 Polymers containing polysaccharides such as alginates or modified alginates |
12/13/2000 | EP0848608B1 Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
12/13/2000 | EP0802784B1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof |
12/13/2000 | EP0702552B1 Solid fat nanoemulsions as drug delivery vehicles |
12/13/2000 | EP0681491B1 Intrapulmonary delivery of hormones |
12/13/2000 | CN1276833A Vaccine |
12/13/2000 | CN1276731A Insoluble insulin compositions |
12/13/2000 | CN1276724A Eprosartan arginyl charge-neutralization-complex and process for its production and formulation |
12/13/2000 | CN1276719A Rapidly disintegrating methylcellulose tablets |
12/13/2000 | CN1276718A Rapidly disintegrating methylcellulose tablets |
12/13/2000 | CN1276716A Effervescent base |
12/13/2000 | CN1276243A Umbilical salves for dropping drug and its preparing process |
12/13/2000 | CN1276239A Anticancer pill and its preparing process |
12/13/2000 | CN1276232A Chinese medicine preparation for treating viral myocarditis |
12/13/2000 | CN1276229A Chinese medicine preparation for treating scrofula and its preparing process |
12/13/2000 | CN1276222A Extract of Aralia mandshurica bark and its application |